Aminopropanol derivatives

Details for Australian Patent Application No. 2004268052 (hide)

Owner Novartis AG

Inventors Zecri, Frederic; Zollinger, Markus; Albert, Rainer; Francotte, Eric

Agent Davies Collison Cave

Pub. Number AU-B-2004268052

PCT Pub. Number WO2005/021503

Priority 0320196.9 28.08.03 GB; 0324206.2 15.10.03 GB

Filing date 27 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 19 November 2009

International Classifications

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61K 31/4035 (2006.01)

C07D 209/46 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 263/14 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/572 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/653 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021503 Priority application(s): WO2005/021503

19 November 2009 Application Accepted

  Published as AU-B-2004268052

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268055-Enhancing the circulating half-life of interleukin-2 proteins

2004268051-Process for the purification of terbinafine